The Quality of Life of the Asthmatic Child Caregiver;Calidad de Vida del Cuidador del Niño Asmático

Gaceta Medica de Mexico

Volumn 140, Issue 2, 2004, Pages 139-145

  Sienra Monge, Juan José Luis ^a,c   Del Río Navarro, Blanca E ^b   Álvarez Amador, Moisés ^b   Blandon Vijil, Virginia ^b   Gómez Chico Velasco, Rebeca ^a  

^a Subdireccion de Ensenanza ^*  (Mexico)

^b Depto de Alergia e Inmunol Clin

^c HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Asthma; Caregivers; Quality of life; Questionnaires

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; SALMETEROL; STEROID;

ARTICLE; ASTHMA; CAREGIVER; CHILD; CHILD CARE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; EMOTION; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; CAREGIVERS; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; TIME FACTORS;

EID: 2442604486     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. National Institute of Health. National Heart, Lung and Blood Institute. Global strategy for asthma management and prevention. Ch. 5. Revised 2002. p. 75.
2. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology. Practice parameters for the diagnosis and treatment of asthma. VI. Asthma management. J Allergy Clin Immunol 1995;96:749-820.
3. Schwarts RH. Pediatric asthma, allergy & immunology. Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. Pharmacologic therapy: the medications, Am Acad Asthma Allergy Clin Immunol 1997;11:59-71.
4. Moore RH, Khan A, Dickey BF. Long-acting inhaled beta 2-agonists in asthma therapy. Chest 1998;113(4):1095-108.
5. Schwarts RH. Pediatric asthma allergy & immunology. Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. Pharmacologic therapy: managing asthma long term. Am Acad Asthma Allergy Clin Immunol 1997;11:81-104.
6. Juniper EF. How important is quality of life in pediatric asthma? Pediatr Pulmonol 1997;(Suppl)15:17-21.
7. Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker B, editor. Quality of life assesment in clinical trials. New York: Raven Press; 1990. p. 11-24.
8. National Heart Lung and Blood Institute National Asthma Education and Prevention Program. Expert Panel Report 2. Guidelines for the diagnosis and managemente of asthma, National Institute of Health Pub No. 97-4051 Bethesda, MD, USA, 1997.
9. Sienra-Monge JJI, Baeza-Bacab MA. Parámetros prácticos para el diagnóstico y tratamiento del niño asmático. 1er ed. Academia Mexicana de Pediatria, México: Intersistemas; 1997. p. 9-46.
10. Ortega-Cisneros M, Ramos-Garcia B, Espinola-Reyna G, Sienra-Monge JJL. Pruebas de función pulmonar en pediatría. Bol Med Hosp Infant Mex 1997:54;47-53.
11. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmetrol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respi Crit Care Med 1996;153:1481-1488.
12. Wilson MM. The association of asthma and obesity. Arch Inter Med 1999;159:2513-2514.
13. Velarde E, Avila C. Evaluación de la calidad de vida. Salud Publica Mex 2002;44:349-361.
14. Guyatt GH, Krinshner B, Jaeschke J. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992;45:1341-1345.
15. Juniper FF, Guyatt EF, Willan A, Griffith LE. Determine a minimal important change in a disease-specific quality of life instrument. J Clin Epidemiol 1994;47:81-87.
16. Juniper EF. How important is quality of life in pediatric asthma? Pediatr Pulmonol 1997;S15:17-21.
17. Guyatt GH, Juniper EF, Feeny DH, Griffith LE, Ferrie PJ. Children and adult perceptions of childhood asthma. Pediatrics 1997;99(2):165-168.
18. Townsend M, Feeney DH, Guyatt GH, Futlong WJ. Evaluation of the burden of illness for pediatric asthmatic patients and their parents. Ann Allergy 1991;67:403-408.
19. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Resp Dis 1993;147:832-838.
20. Juniper E. Minimum skills required by children to complete health-related quality of life instrument for asthma: comparison of measurement properties. Eur Resp J 1997;10:2285-2294.
21. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health related quality of life instrument In: Spinker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2rd ed. New York: Raven Press, Ltd.; 1995. p. 49-56.
22. Rutten-van Molken MP, Clusters F. Comparison of performance of four instruments in evaluting the effects of salmeterol on asthma quality of life. Eur Resp J 1995;8:888-898.
23. Juniper EF, Guyatt, GH, Feeny PJ, Ferrie LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996;5:35-46.
24. Juniper EF, Guyatt, GH, Feeny PJ, Ferrie LE, Townsend M. Measuring quality of life in the parents of children with asthma. Qual Life Res 1996;5:27-34.
25. Kemp J, Cook D. Salmeterol improves quality of life in patients with asthma requiring inhalated corticosteroids. Allergy Clin Immunol 1998;101:188-95.
26. The British Guideline on Asthma Management, 1995. Review and position statement. Thorax 1997;52(Suppl 1):S1-S21.
27. Warner JO, Naspitz CK. Third International Pediatric Consensus Statement on Management of Childhood Asthma. Pediatr Pulmonol 1998;25:1-17.
28. Fish JE, Peters SP. Airway remodeling and persistent airway obstrucction in asthma. J Allergy Clin Immunol 1999;104:509-516.